- Home
- RNGR vs RGNX Comparison
RNGR vs RGNX Comparison
Compare RNGR & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNGR
- RGNX
- Stock Information
- Founded
- RNGR 2017
- RGNX 2008
- Country
- RNGR United States
- RGNX United States
- Employees
- RNGR N/A
- RGNX N/A
- Industry
- RNGR Oilfield Services/Equipment
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RNGR Energy
- RGNX Health Care
- Exchange
- RNGR Nasdaq
- RGNX Nasdaq
- Market Cap
- RNGR 327.9M
- RGNX 372.1M
- IPO Year
- RNGR 2017
- RGNX 2015
- Fundamental
- Price
- RNGR $17.56
- RGNX $7.37
- Analyst Decision
- RNGR Hold
- RGNX Strong Buy
- Analyst Count
- RNGR 2
- RGNX 12
- Target Price
- RNGR $12.50
- RGNX $36.00
- AVG Volume (30 Days)
- RNGR 135.6K
- RGNX 1.8M
- Earning Date
- RNGR 03-03-2025
- RGNX 02-25-2025
- Dividend Yield
- RNGR 1.14%
- RGNX N/A
- EPS Growth
- RNGR N/A
- RGNX N/A
- EPS
- RNGR 0.63
- RGNX N/A
- Revenue
- RNGR $579,500,000.00
- RGNX $84,327,000.00
- Revenue This Year
- RNGR N/A
- RGNX $2.92
- Revenue Next Year
- RNGR $12.00
- RGNX $234.86
- P/E Ratio
- RNGR $27.89
- RGNX N/A
- Revenue Growth
- RNGR N/A
- RGNX N/A
- 52 Week Low
- RNGR $9.27
- RGNX $6.56
- 52 Week High
- RNGR $17.90
- RGNX $28.80
- Technical
- Relative Strength Index (RSI)
- RNGR 69.98
- RGNX 42.98
- Support Level
- RNGR $15.33
- RGNX $6.98
- Resistance Level
- RNGR $16.60
- RGNX $7.70
- Average True Range (ATR)
- RNGR 0.56
- RGNX 0.57
- MACD
- RNGR 0.24
- RGNX 0.02
- Stochastic Oscillator
- RNGR 90.03
- RGNX 35.53
About RNGR Ranger Energy Services Inc.
Ranger Energy Services Inc is a provider of onshore high specification (high-spec) well service rigs, wireline services, and additional processing solutions and ancillary services in the United States. It offers a range of well site services to U.S. exploration and production (E&P) companies that are fundamental to establishing and enhancing the flow of oil and natural gas throughout the productive life of a well. The segments of the group are High Specification Rigs, Wireline Services and Processing Solutions and Ancillary Services, of which key revenue is derived from High Specification Rigs segment.
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.